We talk a lot about value-based care because we believe our products can truly change the face of vascular access for both patients and healthcare providers as we know it. James Biggins, AVI founder, president, and CEO, dives into this topic in our latest #AskAVI. To learn more, visit: https://loom.ly/IA_Ou_Q #ValueBasedCare #TransformingVascularAccess
Access Vascular, Inc.
医疗设备制造业
Billerica，Massachusetts 5,334 位关注者
HydroMID features a novel biomaterial designed to reduce complications?such as catheter occlusion & thrombosis events.
关于我们
Access Vascular was founded to address the most common and costly complications of intravenous therapy: infection, thrombosis, and phlebitis. Taking a foundationally different approach to thrombus reduction, the company manufactures intravenous catheters from a hydrophilic material which retains significant amounts of water. Engineered to mimic the body’s natural chemistry, Access Vascular catheters are designed to evade the foreign body response and complications that come with it. Our cleared products are HydroPICC?and HydroMID?. For more information, please visit www.accessvascularinc.com.
- 网站
-
https://www.AccessVascularInc.com
Access Vascular, Inc.的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- Billerica，Massachusetts
- 类型
- 私人持股
- 创立
- 2015
- 领域
- Medical Device、Bio-materials、Vascular access、Product Development、Healthcare和Drug Delivery
地点
-
主要
获取路线
749 Middlesex Tpke
US，Massachusetts，Billerica，01821
Access Vascular, Inc.员工
动态
-
We knew that in order to address the challenges in obtaining and sustaining vascular access, we had to take a foundationally different approach to thrombus reduction. Enter our consistently hydrophilic, novel material that better mimics the body's natural chemistry compared to traditional catheters. By absorbing water during hydration to camouflage itself to the body, products like our HydroPICC can reduce harmful foreign body responses. Learn more: https://loom.ly/xDISr64 #transformingvascularaccess
-
Did you know that around 90% of patients entering a hospital will receive a vascular access device at some point during their treatment? Roughly 30% of those patients will experience catheter complications. AVI was created because our founders knew that there was a better way and after shadowing clinicians and understanding the underlying causes of standard catheter issues, they created a new technology that is revolutionizing the industry. Learn more: https://loom.ly/6YZwsjg
-
-
Happy National Certified Nurses Day! ?? Today, we celebrate the dedication and expertise of certified nurses everywhere. Whether you hold a VA-BC, CRNI, CIC or any other specialty certification, your commitment to excellence ensures the highest level of patient care. Your expertise matters, and we appreciate all that you do! Tag a certified nurse to show your appreciation! ?? #CertifiedNursesDay #VascularAccess #NursingExcellence #VA_BC #CRNI
-
-
?? Hospital Onset Bacteremia: A Growing Challenge Did you know HOB cases are 4x more common than CLABSI events and can significantly impact patient outcomes and healthcare costs? Are you ready for the changes coming with the focus on HOB? ?? Read our latest blog to learn more about what's coming: https://loom.ly/NhPt5jU #InfectionPrevention #HospitalOnsetBacteremia #HealthcareInnovation #AccessVascular #PatientSafety
-
-
?? The Time to Innovate is Now With endovascular devices identified as the 2nd leading cause of hospital-onset bacteremia (HOB), it's time to rethink how we approach vascular access. At Access Vascular, our midlines are designed to address critical challenges in patient care - it’s worth noting that we’ve never had a reported case of CLABSI or CRBSI associated with our technology. Is now the time to try a midline with anti-thrombogenic properties? https://lnkd.in/gw5fPQMY #VascularAccess #PatientSafety #InnovationInCare #HospitalOnsetBacteremia
-
-
Built with our proprietary hydrophilic biomaterial, the HydroPICC? and HydroMID? are quickly becoming a preferred option among healthcare professionals. Why? Because when it comes to keeping patients clear of complications such as thrombosis and phlebitis that can be brought on by traditional catheters, our products continue to perform better than these outdated devices in clinical studies.* Learn more about the technology that's #transformingvascularaccess: https://loom.ly/B1YIPOo *Presented at AVA 2021. Data on file at Access Vascular Inc.
-
"Prove it for yourself at your facility. Prove that it works better." Don't take our word for it or even Dr. Nancy Moureau . Prove it for yourself! We welcome the opportunity to setup an evaluation at your facility and support you in comparing the outcomes and completion of therapy with the Access Vascular MIMIX technology versus your existing PICC or midline catheters. Please contact us to setup your evaluation: https://loom.ly/gSt1u8E #datadriven #nurses #vascularaccess
-
Don’t give thrombus an opening. By using a unique material that is consistently hydrophilic, our catheters are able to mimic the body's natural chemistry to keep from eliciting the foreign body response that leads to the thrombosis cascade. With this one-of-a-kind technology, our goal is to help patients and take the burden off staff and hospitals. Discover how we are #transformingvascularaccess: https://loom.ly/IWLV97Y
-
?? Fellow Medtech Innovators - this one's for you! Join us on March 6 at the Medtech Symposia and Gala where we come together to shape the future of healthcare. ?? Access Vascular will be there, sharing insights and celebrating advancements in patient care. This is your chance to discover the latest innovations and network with other medtech innovators. ?? When: March 6 ?? Where: Boston, MA Hope we see you there! Link to register: https://loom.ly/_vfalNE #Medtech #Innovation #MedicalDevices #HealthcareTech #MedtechSymposia #AccessVascular
-